OTCMKTS:SZLSF StageZero Life Sciences (SZLSF) Stock Price, News & Analysis → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free SZLSF Stock Alerts $0.04 +0.01 (+48.15%) (As of 04/24/2024) Add Compare Share Share Today's Range$0.03▼$0.0450-Day Range$0.03▼$0.0452-Week Range$0.03▼$0.06Volume15,600 shsAverage Volume11,696 shsMarket Capitalization$4.94 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Get StageZero Life Sciences alerts: Email Address Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details About StageZero Life Sciences Stock (OTCMKTS:SZLSF)StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company's lead product is Aristotle, a mRNA-based multi-cancer panel test for for the detection of multiple discrete cancers from a single sample of blood. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; Prostate Health Index, a screening test for prostate cancer; BreastSentry, a test to determine a woman's risk for developing breast cancer; and COVID-19 Tests. The company is based in Richmond Hill, Canada.Read More SZLSF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SZLSF Stock News HeadlinesApril 5, 2024 | finanznachrichten.deStageZero Life Sciences Ltd: StageZero Life Sciences Provides an Update on Application for Management Cease Trade OrderNovember 15, 2023 | seekingalpha.comStagezero Life Sciences GAAP EPS of -$0.01, revenue of $0.75MApril 29, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)June 7, 2023 | finance.yahoo.comStageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special MeetingMay 17, 2023 | theglobeandmail.comDually-Listed Healthcare Stock Rallies On Q1 ResultsMay 15, 2023 | finance.yahoo.comStageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023April 4, 2023 | msn.comStagezero Life Sciences GAAP EPS of -$0.09, revenue of $0.7MMarch 30, 2023 | finance.yahoo.comStageZero to Issue Q4 2022 Financial Results on Friday March 31April 29, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)March 29, 2023 | finance.yahoo.comStageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30February 15, 2023 | finance.yahoo.comResults from METRICs Study Informs Expansion of StageZero's New Care Oncology ProtocolJanuary 12, 2023 | finanznachrichten.deStageZero Life Sciences Ltd: StageZero Life Sciences Announces Extension of Warrants Expiring in January 2023January 12, 2023 | finance.yahoo.comStageZero Life Sciences Announces Extension of Warrants Expiring in January 2023November 15, 2022 | seekingalpha.comStageZero Life Sciences Ltd. (SZLSF) Q3 2022 Earnings Call TranscriptNovember 12, 2022 | finance.yahoo.comStageZero to Hold Q3 2022 Operational and Financial Results Conference Call on Tuesday November 15, 2022August 19, 2022 | finanznachrichten.deStageZero Life Sciences Ltd: StageZero Announces Solutions for Employers to Help Improve Cancer OutcomesAugust 12, 2022 | finance.yahoo.comStageZero to Hold Q2 2022 Operational and Financial Results Conference Call on Tuesday August 16, 2022May 26, 2022 | seekingalpha.comStageZero Life Sciences CFO resignsMay 25, 2022 | finance.yahoo.comStageZero Life Sciences Partners with DiagnoseAtHome to Offer Aristotle(R) Multi-Cancer Blood Test in Canada and USAMay 17, 2022 | finanznachrichten.deStageZero Life Sciences Ltd: StageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational UpdateMay 17, 2022 | finance.yahoo.comStageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational UpdateApril 6, 2022 | finance.yahoo.comStageZero Life Sciences, Ltd Announces Corporate UpdateApril 1, 2022 | finance.yahoo.comStageZero Life Sciences, Ltd Announces Q4 2021 and Year End Financial Results and Operational UpdateMarch 31, 2022 | finanznachrichten.deStageZero Life Sciences Ltd: StageZero Life Sciences Launches AVRT in the UKMarch 31, 2022 | finance.yahoo.comStageZero Life Sciences Launches AVRT(TM) in the UKMarch 14, 2022 | finanznachrichten.deStageZero Life Sciences Ltd: CORRECTING AND REPLACING: StageZero Life Sciences Announces Availability of COC Protocol in EuropeMarch 14, 2022 | lse.co.ukCQN:StageZero Announces COC Protocol in EuropeSee More Headlines Receive SZLSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolOTCMKTS:SZLSF CUSIPN/A CIK1454263 Webwww.stagezerolifesciences.com Phone(855) 420-7140Fax905-209-2031Employees40Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,410,000.00 Net Margins-418.64% Pretax Margin-418.63% Return on EquityN/A Return on Assets-1,872.84% Debt Debt-to-Equity RatioN/A Current Ratio0.04 Quick Ratio0.03 Sales & Book Value Annual Sales$3.80 million Price / Sales1.30 Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / Book-0.57Miscellaneous Outstanding Shares123,533,000Free Float120,395,000Market Cap$4.94 million OptionableNot Optionable Beta0.61 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. James R. Howard-TrippExecutive Chairman & CEODr. Choong-Chin Liew Ph.D.Co-FounderMr. Warren Whitehead C.M.A. (Age 72)CPA, Chief Accountant Key CompetitorsNavidea BiopharmaceuticalsNYSE:NAVBStageZero Life SciencesOTCMKTS:GNWSFMyMD PharmaceuticalsNASDAQ:MYMDVirax Biolabs GroupNASDAQ:VRAXBiomericaNASDAQ:BMRAView All Competitors SZLSF Stock Analysis - Frequently Asked Questions How have SZLSF shares performed in 2024? StageZero Life Sciences' stock was trading at $0.0294 at the start of the year. Since then, SZLSF shares have increased by 36.1% and is now trading at $0.04. View the best growth stocks for 2024 here. How do I buy shares of StageZero Life Sciences? Shares of SZLSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SZLSF) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryHas Jeff Bezos Found the Next Nvidia?InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding StageZero Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
